Delivery Order SPE2DB22D3011-SPE2DB25FQ2EQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,007.16 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W vaccine kits (2 vials each). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 24, 2025. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on July 28, 2025, for Menveo A-C-Y-W vaccine kits (2 vials) with a ceiling value of $13,567.88 under firm fixed-price terms. This non-set-aside contract is scheduled for completion by July 29, 2025, with performance taking place at the company's Conshohocken, Pennsylvania headquarters. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC SPE2DX)...
- The Defense Logistics Agency awarded a delivery order valued at $7,087.92 to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,060.16 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W vaccine kits (2 vials). The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price delivery order, valued at $3,789.19, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by July 31, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL vaccine, with a ceiling value of $6,449.00. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Menveo 1 vial combination vaccine (A-C-Y-W-135-diphtheria), 0.5 mL. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $6,159.30 and is scheduled for completion by August 13, 2025. The award is issued under a non-set-aside procurement and represents a child contract action...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.70 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials). This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a non-competitive award, indicating the product was procured through an existing contract vehicle rather than a new...
- The Defense Logistics Agency awarded a $5,035.80 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. This is a firm fixed-price, competitively awarded contract with performance to be completed by August 12, 2025, and fulfillment based in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a single transaction under AmerisourceBergen's existing federal contract...
- The Defense Logistics Agency awarded a $5,559.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W vaccine kits (2 vials). The award, issued on July 29, 2025, with completion targeted for July 30, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania will serve as the place of performance. This delivery order is issued under the company's existing Indefinite Delivery...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2EQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials) under a firm fixed price contract valued at $3,357.20. The order was competitively awarded with no set-aside designation and is scheduled for completion by August 13, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026, which serves military and federal healthcare systems globally. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen Drug Corp regularly fulfills federal medical procurement requirements through the DLA Medical Supply Chain. The company supplies a broad portfolio of pharmaceutical products and medical commodities, including vaccines, specialty medications, and medical devices to support military healthcare programs and other federal health systems. This contract award demonstrates the company's continued role as a critical vendor in the federal vaccine and pharmaceutical supply chain supporting defense and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/12/25 |